Literature DB >> 30116065

Ethnic disparities in community antibacterial dispensing in New Zealand, 2015.

Naomi Whyler1, Andrew Tomlin2, Murray Tilyard2, Mark Thomas3.   

Abstract

AIMS: There are significant ethnic disparities in the incidence of various infectious diseases in New Zealand. Antimicrobial stewardship interventions which ignore these disparities may have negative effects on the health of some ethnic groups. We aimed to determine the relationship between ethnicity and community antimicrobial dispensing in New Zealand, to inform the development of antimicrobial stewardship interventions in New Zealand.
METHODS: Demographic data on all patients registered with a general practice in New Zealand and on all community pharmacy antibacterial dispensings during 2015 were obtained from national healthcare databases. The rates of dispensing were measured as the number of dispensings per 1,000 population per day and as defined daily doses per 1,000 population per day.
RESULTS: The rate of community antibacterial dispensing for the total population surveyed was 3.01 dispensings per 1,000 population per day, and was 3.49 for Pacific, 3.23 for Māori, 3.02 for European, 2.70 for Middle Eastern, Latin American and African, and 2.35 for Asian people. In all ethnic groups the rate of community antibacterial dispensing increased with increasing socioeconomic deprivation. Seasonal variation in antibacterial dispensing ranged between 34% in Asian people and 24% in European people.
CONCLUSIONS: The ethnic disparities in the rates of antibacterial dispensing in New Zealand are consistent with, but less marked than, the ethnic disparities in the incidence of infectious diseases in New Zealand. Improved community-wide understanding of both the benefits and the harms of antibacterial medicines is necessary to support improved antibacterial use in New Zealand in the future.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30116065

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  5 in total

1.  Outcomes of adults with invasive meningococcal disease with reduced penicillin susceptibility in Auckland 2004-2017.

Authors:  Matthew Broom; Emma Best; Helen Heffernan; Sara Svensson; Maria Hansen Hygstedt; Rachel Webb; Nick Gow; David Holland; Mark Thomas; Simon Briggs
Journal:  Infection       Date:  2022-08-18       Impact factor: 7.455

2.  Māori Experiences and Beliefs about Antibiotics and Antimicrobial Resistance for Acute Upper Respiratory Tract Symptoms: A Qualitative Study.

Authors:  Kayla Hika; Matire Harwood; Stephen Ritchie; Amy Hai Yan Chan
Journal:  Antibiotics (Basel)       Date:  2022-05-26

3.  Racial/Ethnic Disparities in Antimicrobial Drug Use, United States, 2014-2015.

Authors:  Mark Thomas; Naomi Whyler; Andrew Tomlin; Murray Tilyard
Journal:  Emerg Infect Dis       Date:  2019-07       Impact factor: 6.883

4.  Examining non-medical prescribing trends in New Zealand: 2016-2020.

Authors:  Rakhee Raghunandan; Carlo A Marra; June Tordoff; Alesha Smith
Journal:  BMC Health Serv Res       Date:  2021-05-03       Impact factor: 2.655

5.  The impacts of New Zealand's COVID-19 epidemic response on community antibiotic use and hospitalisation for pneumonia, peritonsillar abscess and rheumatic fever.

Authors:  Eamon Duffy; Mark Thomas; Thomas Hills; Stephen Ritchie
Journal:  Lancet Reg Health West Pac       Date:  2021-06-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.